Skip to main content

Market Overview

Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To Conviction List

Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To Conviction List

After a year of sector underperformance, several factors are coalescing to make 2020 a better year for the health care sector, Goldman Sachs said Monday as it added three stocks to its conviction list.

The Analyst

Asad Haider added Amgen, Inc. (NASDAQ: AMGN), UnitedHealth Group Inc (NYSE: UNH) and Dentsply Sirona Inc. (NASDAQ: XRAY) to the firm’s Americas Conviction List.

Goldman has Buy ratings on all three stocks and a $270 price target on Amgen, a $330 price target on UnitedHealth and $66 price target on Dentsply Sirona. 

Takeways On Amgen, UnitedHealth, Dentsply Sirona 

Overall, Haider is more bullish on health care stocks generally and said he expects a rebound from a down year. 

A strong biotech innovation cycle is starting,and there’s a sense that any near-term aggressive government action is unlikely, with policymakers focused on the upcoming election, the analyst said. 

The policymaking landscape also includes a lower likelihood of Medicare-for-All in the next president's first term, as most candidates are not pushing the policy, he said. 

“Investors are entering 2020 with a better understanding of the heavy lifting required to legislate aggressive health care policy proposals,” Haider said. 

The analyst has above-consensus estimates for Amgen's revenue and EPS, adding that stock performance is likely to follow earnings revisions in a setting with receding headwinds and new pipeline readouts.

UnitedHealth Group also is likely to follow positive EPS revisions higher, “even if the multiple holds its slight historical relative P/E discount,” Haider said. 

Dentsply Sirona is likely to see continued demand for its Primescan Intraoral scanner product, leading to market share gains along with savings from restructuring tracking ahead of plan, the analyst said. 

Price Action

UnitedHealth Group shares were up 2.5% at the time of publication, while Amgen shares were higher by more than 3% and Dentsply Sirona shares were up 1.99%. 

Related Links:

Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020

What You Need To Know About Elizabeth Warren's Plan To Pay For 'Medicare For All'

Latest Ratings for AMGN

Mar 2021BarclaysMaintainsEqual-Weight
Mar 2021Morgan StanleyMaintainsOverweight
Mar 2021SVB LeerinkMaintainsMarket Perform

View More Analyst Ratings for AMGN
View the Latest Analyst Ratings


Related Articles (AMGN + UNH)

View Comments and Join the Discussion!

Posted-In: 2020 election Asad HaiderAnalyst Color Health Care Price Target Reiteration Analyst Ratings General Best of Benzinga

Latest Ratings

NIUDaiwa CapitalInitiates Coverage On41.5
QMCONorthland Capital MarketsInitiates Coverage On12.0
IBKRJefferiesInitiates Coverage On89.0
MRETFTD SecuritiesDowngrades18.5
SWKSGoldman SachsDowngrades135.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at